Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
central retinal artery occlusion
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
diabetes mellitus
glucagon-like peptide-1
obesity
prevention of neurologic disorders
semaglutide
sleep apnea, obstructive
tirzepatide
treatment of neurologic disorder
weight loss
Showing articles 200 to 250 of 1213 << Previous Next >>

Transition to Adult Care for Children with Chronic Neurological Disorders
Ann Neurol 69:437-444, Camfiled, P. & Camfield, C., 2011

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Fulminant Encephalopathy with Basal Ganglia Hyperintensities in HIV-infected Drug Users
Neurol 77:923, Finelli, P.F., 2011

Results of the Expanded HIV Testing Initiative - 25 Jurisdictions, United States 2007-2010
JAMA 306:698-700, , 2011

Screening for HIV Infection A Healthy, "Low-Risk" 42-Year-Old Man
JAMA 306:637-644, Libman, H., 2011

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011

Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011

Spinal Muscular Atrophy A Timely Review
Arch Neurol 68:979-984, Kolb, S.J.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Routine HIV Screening - What Counts in Evidence-Based Policy?
NEJM 365:1265-1268, Bayer, R. and Oppenheimer G.M., 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

HIV Screening of Male Inmates During Prison Intake Medical Evaluation - Washington, 2006-2010
JAMA 306:1756-1757, Strick, L.B., 2011

Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011

Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011

Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011

Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011

Chronic Inflammatory Demyelinating Polyneuropathy: Etiology, Clinical Features, and Diagnosis
UpToDate, Sept, Lewis, R., 2010

AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010

The erythrocyte sedimentation rate in HIV: a neglected parameter?
AIDS 24:2773-2775, Lowe, D., 2010

Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010

Imaging Manifestations of Progressive Multifocal Leukoencephalopathy
Clinical Radiol 65:431-439, Shah,R.,et al, 2010

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Coccidioidal Meningitis: Clinical Presentation and Management in the Fluconazole Era
Medicine 89:251-284, Mathisen,G.,et al, 2010

New Drugs in Migraine Treatment and Prophylaxis: Telcagepant and Topiramate
Lancet 376:645-655, Edvinsson,L. &Linde,M., 2010

Glucose Transporter-1 Deficiency Syndrome: The Expanding Clinical and Genetic Spectrum of a Treatable Disorder
Brain 133:655-670, Leen,W.G., et al, 2010

Is the Diagnosis at Hand?
The Lancet 375:1134, Holmes,M.V., et al, 2010

Absence Epilepsies With Widely Variable Onset are a Key Feature of Familial GLUT1 Deficiency
Neurol 75:432-440, Mullen,S.A., et al, 2010

Utility of Molecular and Serodiagnostic Tools in Cerebral Toxoplasmosis With and Without Tuberculous Meningitis in AIDS Patients
Ann Indian Acad Neurol 13:263-274, Adurthi, S.,et al, 2010

Cerebral Toxoplasmosis in Acquired Immunodeficiency Syndrome (AIDS) Patients also Provides Unifying Pathophysiologic Hypotheses for Holmes Tremor
BMC Neurol 10:37, Lekoubou, A.,et al, 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

The stages and natural history of HIV infection
Up to date: Sept, Bartlett, J.G.,et al, 2010

Eccentric Target Sign in Cerebral Toxoplasmosis - Neuropathological Correlate to the Imaging Feature
J Magn Reson Imaging 31:1469-1472, Kumar, G.S.,et al, 2010

Multiple Ring-Enhancing Lesions of the Brain
J Postgrad Med 56:307-316, Garg, R.K. & Sinha, M.K., 2010

Frequent Hemorrhagic Lesions in Cerebral Toxoplasmosis in AIDS Patients
J Neuroimaging 19:169-173, Bhagavati, S. & Choe, J., 2009

Small Fiber Neuropathy: A Burning Problem
Cleve Clin J Med 76:297-305, Tavee, J. & Zhou, L., 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

Efficacy of Treatment of MS with IFN B-1b or Glatiramer Acetate by Monthly Brain MRI in the BECOME Study
Neurol 72:1976-1983,1972, Cadavid,D.,et al, 2009

Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009

Real-Life Impact of Early Interferon� Therapy in Relapsing Multiple Sclerosis
Ann Neurol 66:513-520, Trojano,M.,et al, 2009

The Present Efficacy of Multiple Sclerosis Therapeutics
Neurol 73:984-990, Klawiter,E.,et al, 2009

Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

Plasmablastic Lymphoma: CNS Involvement, Coexistence of Other Malignancies, Possible Viral Etiology, and Dismal Outcome
Ann Hematol 88:351-358, Ustun, C.,et al, 2009



Showing articles 200 to 250 of 1213 << Previous Next >>